IFN-α activates `silent' coeliac disease in predisposed patients

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1031, 2004-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IFN-α carries mental-health risk

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Peginterferon-α: Exacerbation of coeliac disease: case report

Reactions Weekly, Vol. 1, Iss. 1300, 2010-01 ,pp. : 40-40

Adis International

Access to resources Recommend Favorite

Interferon (IFN)-α-2a is effective in patients with hepatitis D virus (HDV) infection, but adjunctive ribavirin does not provide additional benefit

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Evaluating EVR to PEG IFN-α-2b/ribavirin therapy worthwhile

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 491, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Sunitinib benefits HRQOL more than IFN-α in renal cell carcinoma

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 523, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite